服务热线
Anti-TIGIT/WUCAM/VSTM3 mAbs [Renvistobart Biosimilar] (MABL-5157)
Anti-PDCD1/CD279/PD1;PDL1/CD274 mAbs [Reozalimab Biosimilar] (MABL-5158)
Anti-IL5 mAbs [Reslizumab Biosimilar] (MABL-5159)
Anti-SOST mAbs [Resugosbart Biosimilar] (MABL-5160)
Anti-RSV gpF mAbs [Retavibart Biosimilar] (MABL-5161)
Anti-PDCD1/CD279/PD1 mAbs [Retifanlimab Biosimilar] (MABL-5162)
Anti-PDL1/CD274 mAbs [Retlirafusp Biosimilar] (MABL-5163)
Anti-TNFRSF4/CD134/OX40 mAbs [Revdofilimab Biosimilar] (MABL-5164)
Anti-CD3;SIGLEC2/CD22 mAbs [Rezetamig Biosimilar] (MABL-5165)
Anti-KLRB1 mAbs [Rezorstobart Biosimilar] (MABL-5166)
Anti-C1S mAbs [Riliprubart Biosimilar] (MABL-5167)
Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Rilogrotug Biosimilar] (MABL-5168)
Anti-HGF/SF mAbs [Rilotumumab Biosimilar] (MABL-5169)
Anti-IL31 (Canine) mAbs [Riltovetbart Biosimilar] (MABL-5170)
Anti-KDR/CD309/VEGFR2 mAbs [Ramucirumab Biosimilar] (MABL-5141)
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
陕ICP备2021006339号